Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
10.71
-0.22 (-2.01%)
Aug 19, 2026, 2:06 PM EDT - Market open

Ardent Health Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,5111,2642,438---
Market Cap Growth
-15.42%-48.14%----
Enterprise Value
3,0533,3284,499---
Last Close Price
10.938.8317.08---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
19.909.3111.59---
Forward PE
9.976.838.79---
PS Ratio
0.240.200.41---
PB Ratio
1.150.751.60---
P/TBV Ratio
4.023.9612.05---
P/FCF Ratio
5.064.8919.12---
P/OCF Ratio
3.002.697.74---
PEG Ratio
2.693.840.12---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
0.480.530.75---
EV/EBITDA Ratio
7.306.918.15---
EV/EBIT Ratio
11.9610.2211.09---
EV/FCF Ratio
10.1212.8735.28---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.301.381.502.212.28-
Debt / EBITDA Ratio
3.313.132.843.994.26-
Debt / FCF Ratio
7.448.9917.9028.43--
Net Debt / Equity Ratio
0.890.961.131.801.83-
Net Debt / EBITDA Ratio
3.653.353.115.455.67-
Net Debt / FCF Ratio
5.066.2413.4523.05-10.12-
Asset Turnover
1.241.231.231.18--
Inventory Turnover
22.7522.7522.9822.42--
Quick Ratio
1.491.421.441.301.38-
Current Ratio
2.111.971.941.631.74-
Return on Equity (ROE)
9.96%14.35%23.01%12.10%--
Return on Assets (ROA)
3.13%3.97%5.24%2.93%--
Return on Invested Capital (ROIC)
6.25%8.01%10.70%6.13%5.75%-
Return on Capital Employed (ROCE)
6.00%7.70%10.10%5.80%5.50%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
5.07%10.74%8.63%---
FCF Yield
19.77%20.45%5.23%---
Payout Ratio
----92.54%40.27%
Buyback Yield / Dilution
-1.33%-6.56%-5.26%---
SEC Filings: 10-K · 10-Q